257 related articles for article (PubMed ID: 37709652)
1. Hematopoietic cell-based and non-hematopoietic cell-based strategies for immune tolerance induction in living-donor renal transplantation: A systematic review.
Annamalai C; Kute V; Sheridan C; Halawa A
Transplant Rev (Orlando); 2023 Dec; 37(4):100792. PubMed ID: 37709652
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic hematopoietic stem-cell transplantation, mixed chimerism, and tolerance in living related donor renal allograft recipients.
Trivedi HL; Vanikar AV; Modi PR; Shah VR; Vakil JM; Trivedi VB; Khemchandani SI
Transplant Proc; 2005 Mar; 37(2):737-42. PubMed ID: 15848518
[TBL] [Abstract][Full Text] [Related]
3. A Large-Scale Bank of Organ Donor Bone Marrow and Matched Mesenchymal Stem Cells for Promoting Immunomodulation and Transplant Tolerance.
Johnstone BH; Messner F; Brandacher G; Woods EJ
Front Immunol; 2021; 12():622604. PubMed ID: 33732244
[TBL] [Abstract][Full Text] [Related]
4. Tolerance induction in HLA disparate living donor kidney transplantation by donor stem cell infusion: durable chimerism predicts outcome.
Leventhal J; Abecassis M; Miller J; Gallon L; Tollerud D; Elliott MJ; Bozulic LD; Houston C; Sustento-Reodica N; Ildstad ST
Transplantation; 2013 Jan; 95(1):169-76. PubMed ID: 23222893
[TBL] [Abstract][Full Text] [Related]
5. Tolerance induction in HLA disparate living donor kidney transplantation by facilitating cell-enriched donor stem cell Infusion: The importance of durable chimerism.
Leventhal JR; Ildstad ST
Hum Immunol; 2018 May; 79(5):272-276. PubMed ID: 29409743
[TBL] [Abstract][Full Text] [Related]
6. Chimerism-Based Tolerance to Kidney Allografts in Humans: Novel Insights and Future Perspectives.
Podestà MA; Sykes M
Front Immunol; 2021; 12():791725. PubMed ID: 35069574
[TBL] [Abstract][Full Text] [Related]
7. Chimerism and tolerance: past, present and future strategies to prolong renal allograft survival.
Tantisattamo E; Leventhal JR; Mathew JM; Gallon L
Curr Opin Nephrol Hypertens; 2021 Jan; 30(1):63-74. PubMed ID: 33186221
[TBL] [Abstract][Full Text] [Related]
8. Successful Induction of Specific Immunological Tolerance by Combined Kidney and Hematopoietic Stem Cell Transplantation in HLA-Identical Siblings.
Fehr T; Hübel K; de Rougemont O; Abela I; Gaspert A; Güngör T; Hauri M; Helmchen B; Linsenmeier C; Müller T; Nilsson J; Riesterer O; Scandling JD; Schanz U; Cippà PE
Front Immunol; 2022; 13():796456. PubMed ID: 35173720
[TBL] [Abstract][Full Text] [Related]
9. Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation.
Leventhal J; Abecassis M; Miller J; Gallon L; Ravindra K; Tollerud DJ; King B; Elliott MJ; Herzig G; Herzig R; Ildstad ST
Sci Transl Med; 2012 Mar; 4(124):124ra28. PubMed ID: 22399264
[TBL] [Abstract][Full Text] [Related]
10. Clinical trials for renal allograft tolerance induction through combined hematopoietic stem cell transplantation: A narrative review.
Hotta K; Hirose T; Kawai T
Int J Urol; 2022 Dec; 29(12):1397-1404. PubMed ID: 36101964
[TBL] [Abstract][Full Text] [Related]
11. HLA molecular mismatches and induced donor-specific tolerance in combined living donor kidney and hematopoietic stem cell transplantation.
Senev A; Tambur AR; Kosmoliaptsis V; Copley HC; García-Sánchez C; Usenko C; Ildstad ST; Leventhal JR
Front Immunol; 2024; 15():1377535. PubMed ID: 38601147
[TBL] [Abstract][Full Text] [Related]
12. Chimerism, graft survival, and withdrawal of immunosuppressive drugs in HLA matched and mismatched patients after living donor kidney and hematopoietic cell transplantation.
Scandling JD; Busque S; Shizuru JA; Lowsky R; Hoppe R; Dejbakhsh-Jones S; Jensen K; Shori A; Strober JA; Lavori P; Turnbull BB; Engleman EG; Strober S
Am J Transplant; 2015 Mar; 15(3):695-704. PubMed ID: 25693475
[TBL] [Abstract][Full Text] [Related]
13. [Transplant tolerance through mixed chimerism].
Zuber J
Nephrol Ther; 2017 Apr; 13 Suppl 1():S127-S130. PubMed ID: 28577733
[TBL] [Abstract][Full Text] [Related]
14. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
15. Immune tolerance induced by hematopoietic stem cell infusion after HLA identical sibling kidney transplantation.
Huang H; Shen Q; Zhou J; Yang X; Cai Q; Shen J; Feng S; Xie W; Jiang H; Chen J
Front Immunol; 2022; 13():995243. PubMed ID: 36081515
[TBL] [Abstract][Full Text] [Related]
16. Tolerance induction: hematopoietic chimerism.
Kawai T; Sachs DH
Curr Opin Organ Transplant; 2013 Aug; 18(4):402-7. PubMed ID: 23838644
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells facilitate the induction of mixed hematopoietic chimerism and islet allograft tolerance without GVHD in the rat.
Itakura S; Asari S; Rawson J; Ito T; Todorov I; Liu CP; Sasaki N; Kandeel F; Mullen Y
Am J Transplant; 2007 Feb; 7(2):336-46. PubMed ID: 17283484
[TBL] [Abstract][Full Text] [Related]
18. HLA identical non-chimeric and HLA disparate chimeric renal transplant tolerance.
Leventhal JR; Mathew JM; Ildstad S; Salomon DR; Kurian SM; Suthanthiran M; Tambur A; Friedewald J; Gallon L; Charette J; Levitsky J; Kanwar Y; Abecassis M; Miller J
Clin Transpl; 2013; ():145-56. PubMed ID: 25095503
[TBL] [Abstract][Full Text] [Related]
19. Tregs and Mixed Chimerism as Approaches for Tolerance Induction in Islet Transplantation.
Pathak S; Meyer EH
Front Immunol; 2020; 11():612737. PubMed ID: 33658995
[TBL] [Abstract][Full Text] [Related]
20. Immune reconstitution/immunocompetence in recipients of kidney plus hematopoietic stem/facilitating cell transplants.
Leventhal JR; Elliott MJ; Yolcu ES; Bozulic LD; Tollerud DJ; Mathew JM; Konieczna I; Ison MG; Galvin J; Mehta J; Badder MD; Abecassis MM; Miller J; Gallon L; Ildstad ST
Transplantation; 2015 Feb; 99(2):288-98. PubMed ID: 25594553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
